Joint Development Committee. (a) The Parties shall establish a Joint Development Committee (the “Joint Development Committee” or “JDC”), comprised of [**] representatives of Ikaria and [**] representatives of BioLineRx, to oversee the Development of Products. Each Party shall make its initial designation of its representatives not later than [**] days after the Effective Date. Each Party may change any one or more of its representatives to the Joint Development Committee at any time upon notice to the other Party.
Appears in 5 contracts
Samples: License and Commercialization Agreement (Bellerophon Therapeutics, Inc.), License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Bellerophon Therapeutics LLC)
Joint Development Committee. (a) The Parties shall establish a Joint Development Committee (the “Joint Development Committee” or “JDC”), comprised of [***] representatives of Ikaria and [***] representatives of BioLineRx, to oversee the Development of Products. Each Party shall make its initial designation of its representatives not later than [***] days after the Effective Date. Each Party may change any one or more of its representatives to the Joint Development Committee at any time upon notice to the other Party.
Appears in 3 contracts
Samples: License and Commercialization Agreement (BioLineRx Ltd.), License and Commercialization Agreement (BioLineRx Ltd.), License and Commercialization Agreement (BioLineRx Ltd.)
Joint Development Committee. (a) The Within [***] following the Option Effective Date, the Parties shall establish a Joint Development Committee joint development committee (the “Joint Development Committee” or the “JDC”), comprised composed of [**] three (3) (or such other number as agreed between the Parties) representatives of Ikaria and [**] representatives of BioLineRxeach Party having clinical, to oversee the Development of Products. Each Party shall make its initial designation of its representatives not later than [**] days after the Effective Date. Each Party may change any one regulatory, or more of its representatives to the Joint Development Committee at any time upon notice to the other manufacturing development roles within such Party., which shall:
Appears in 2 contracts
Samples: License and Collaboration Agreement (Syros Pharmaceuticals, Inc.), License and Collaboration Agreement (Global Blood Therapeutics, Inc.)
